Patient Capital Management’s NVIDIA NVDA Stock Holding History

Patient Capital Management’s Portfolio NVDA Stock Details NVDA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$142M	Sell	709,587 -1,528	-0.2%	-$314K	4.65%	6
2026 Q1	$124M	Buy	711,115 +72,301	+11%	+$13.3M	4.53%	6
2025 Q4	$119M	Buy	638,814 +6,130	+1%	+$1.14M	4.6%	7
2025 Q3	$118M	Sell	632,684 -1,489	-0.2%	-$260K	4.73%	6
2025 Q2	$100M	Buy	634,173 +7,221	+1%	+$909K	4.52%	7
2025 Q1	$67.9M	Buy	626,952 +18,389	+3%	+$2.33M	3.49%	13
2024 Q4	$81.7M	Sell	608,563 -165	-0%	-$22.7K	3.77%	8
2024 Q3	$73.9M	Buy	608,728 +2,889	+0.5%	+$341K	3.63%	9
2024 Q2	$74.8M	Sell	605,839 -221	-0%	-$22.3K	3.98%	9
2024 Q1	$54.8M	Buy	+606,060	New	+$43.9M	2.67%	15

Other funds holding NVDA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Patient Capital Management's NVDA Position: Q2 2026 in Review

Patient Capital Management reduced its NVIDIA (NVDA) stake by 0.21% in Q2 2026, selling an estimated $314K and leaving 709,587 shares worth $142M. The position accounts for 4.65% of the portfolio, ranked #6.

Patient Capital Management first reported a position in NVDA in Q1 2024 and has held it in 10 quarters since. 5,980 funds tracked by Wall St. Rank hold NVDA as of Q2 2026.

Patient Capital Management held 709,587 shares of NVIDIA worth $142M as of Q2 2026.
Patient Capital Management sold 1,528 NVIDIA shares in Q2 2026, an estimated $314K.
NVIDIA made up 4.65% of Patient Capital Management's portfolio in Q2 2026, its #6 holding.
Patient Capital Management first reported a position in NVIDIA in Q1 2024 and has held it in 10 quarters since.
5,980 funds tracked by Wall St. Rank held NVIDIA as of Q2 2026.

Based on Patient Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.